Funding for this research was provided by:
Alnylam Japan KK (Alnylam Japan KK)
Article History
Received: 30 March 2023
Accepted: 6 September 2023
First Online: 8 December 2023
Declarations
:
: Not applicable; database study using deidentified and anonymous data.
: Not applicable; database study using deidentified and anonymous data.
: YH reported receiving consultant fees from Alnylam Japan KK. YY reported being employed by Alnylam Japan KK and owning stock or stock options in Alnylam Pharmaceuticals. TA declares that he has no competing interests.